Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 401

1.

Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.

Francis JH, Berry D, Abramson DH, Barker CA, Bergstrom C, Demirci H, Engelbert M, Grossniklaus H, Hubbard B, Iacob CE, Jaben K, Kurli M, Postow MA, Wolchok JD, Kim IK, Wells JR.

Ophthalmology. 2019 Sep 24. pii: S0161-6420(19)32085-8. doi: 10.1016/j.ophtha.2019.09.018. [Epub ahead of print]

PMID:
31708274
2.

Impact of enucleation on adult retinoblastoma survivors' quality of life: A qualitative study of survivors' perspectives.

Banerjee SC, Pottenger E, Petriccione M, Chou JF, Ford JS, Sklar CA, Robison LL, Kleinerman RA, Oeffinger KC, Francis JH, Abramson DH, Dunkel IJ, Friedman DN.

Palliat Support Care. 2019 Nov 8:1-10. doi: 10.1017/S1478951519000920. [Epub ahead of print]

PMID:
31699178
3.

Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.

Kleinerman RA, Schonfeld SJ, Sigel BS, Wong-Siegel JR, Gilbert ES, Abramson DH, Seddon JM, Tucker MA, Morton LM.

J Clin Oncol. 2019 Dec 10;37(35):3436-3445. doi: 10.1200/JCO.19.01096. Epub 2019 Oct 17.

PMID:
31622129
4.

Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.

Zauderer MG, Jayakumaran G, DuBoff M, Zhang L, Francis JH, Abramson DH, Cercek A, Nash GM, Shoushtari A, Chapman P, D'Angelo S, Arnold AG, Siegel B, Fleischut MH, Ni A, Rimner A, Rusch VW, Adusumilli PS, Travis W, Sauter JL, Zehir A, Mandelker D, Ladanyi M, Robson M.

J Thorac Oncol. 2019 Nov;14(11):1989-1994. doi: 10.1016/j.jtho.2019.07.002. Epub 2019 Jul 16.

PMID:
31323388
5.

A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma.

Farouk Sait S, Haque S, Karimi S, Rebeiz KJ, Francis JH, Marr BP, Abramson DH, Souweidane MM, Dunkel IJ.

J Pediatr Hematol Oncol. 2019 Jun 27. doi: 10.1097/MPH.0000000000001523. [Epub ahead of print]

PMID:
31259824
6.

Chemoreduction of Orbital Recurrence of Uveal Melanoma by Intra-Arterial Melphalan.

Francis JH, Barker CA, Yin VT, Carvajal RD, Chapman P, Abramson DH, Gobin YP.

Ocul Oncol Pathol. 2019 Apr;5(3):186-189. doi: 10.1159/000490061. Epub 2018 Oct 9.

7.

Iris Mass in a 2-Year-Old.

Abramson DH, Dhar LS, Francis JH.

Ophthalmol Retina. 2018 Sep;2(9):905. doi: 10.1016/j.oret.2018.06.010. Epub 2018 Sep 4. No abstract available.

PMID:
31047223
8.

Early Diagnosis and Management of Aggressive Posterior Vitreoretinopathy Presenting in Premature Neonates.

Gupta MP, Yonekawa Y, Campbell JP, Rusu I, Zahid S, Patel SN, Chau F, Jonas KE, Oltra E, Orlin A, Chang J, Horowitz J, Abramson DH, Marr B, Capone A, Paul Chan RV.

Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):201-207. doi: 10.3928/23258160-20190401-01.

PMID:
30998240
9.

Pseudomelanoma (with Cataract) in a Child Caused by Amniocentesis.

Abramson DH, Francis JH.

Ophthalmology. 2019 Apr;126(4):590. doi: 10.1016/j.ophtha.2019.01.025. No abstract available.

PMID:
30910042
10.

What's New in Intra-Arterial Chemotherapy for Retinoblastoma?

Abramson DH, Francis JH, Gobin YP.

Int Ophthalmol Clin. 2019 Spring;59(2):87-94. doi: 10.1097/IIO.0000000000000266. Review. No abstract available.

PMID:
30908282
11.

Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration.

Winter U, Aschero R, Fuentes F, Buontempo F, Zugbi S, Sgroi M, Sampor C, Abramson DH, Carcaboso AM, Schaiquevich P.

Int J Mol Sci. 2019 Mar 2;20(5). pii: E1077. doi: 10.3390/ijms20051077.

12.

Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016.

Kleinerman RA, Tucker MA, Sigel BS, Abramson DH, Seddon JM, Morton LM.

J Natl Cancer Inst. 2019 Sep 1;111(9):961-969. doi: 10.1093/jnci/djy227.

PMID:
30698734
13.

Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.

Levin AM, Francis JH, McFadden M, Brodie S, Gobin YP, Abramson DH.

PLoS One. 2019 Jan 16;14(1):e0210647. doi: 10.1371/journal.pone.0210647. eCollection 2019.

14.

SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR ARCHITECTURE IN FELLOW EYES OF PATIENTS WITH CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.

Sobol EK, Francis JH, Abramson DH, Freund KB, Spaide RF, Barbazetto I.

Retina. 2019 Jan 9. doi: 10.1097/IAE.0000000000002438. [Epub ahead of print]

PMID:
30633085
15.

Fabrication of a custom brachytherapy appliance.

Drew A, Abramson DH, Wolden SL, Golden M, Randazzo J.

J Prosthet Dent. 2019 Mar;121(3):535-537. doi: 10.1016/j.prosdent.2018.07.002. Epub 2018 Dec 13. Review.

PMID:
30554822
16.

Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma.

Francis JH, Catalanotti F, Landa J, Barker CA, Shoushtari AN, Abramson DH.

Br J Ophthalmol. 2019 Sep;103(9):1266-1271. doi: 10.1136/bjophthalmol-2018-312612. Epub 2018 Oct 31.

PMID:
30381389
17.

Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017.

Lu JE, Francis JH, Dunkel IJ, Shields CL, Yu MD, Berry JL, Kogachi K, Skalet AH, Miller AK, Santapuram PR, Daniels AB, Abramson DH.

Br J Ophthalmol. 2019 Sep;103(9):1272-1277. doi: 10.1136/bjophthalmol-2018-312915. Epub 2018 Oct 25.

18.

Re: Skalet et al.: Screening children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists (Ophthalmology. 2018;125:453-458).

Abramson DH.

Ophthalmology. 2018 Sep;125(9):e63-e64. doi: 10.1016/j.ophtha.2018.03.029. Epub 2018 Aug 21. No abstract available.

PMID:
30143104
19.

Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab.

Francis JH, Slakter JS, Abramson DH, Odrich SA, Gobin YP.

Am J Ophthalmol Case Rep. 2018 May 24;11:49-51. doi: 10.1016/j.ajoc.2018.05.007. eCollection 2018 Sep.

20.

Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.

Francis JH, Roosipu N, Levin AM, Brodie SE, Dunkel IJ, Gobin YP, Abramson DH.

Neoplasia. 2018 Aug;20(8):757-763. doi: 10.1016/j.neo.2018.05.007. Epub 2018 Jun 22.

21.

Clinicopathological Correlation of Choroidal Invasion in Retinoblastoma.

Abramson DH, Folberg R, Francis JH.

JAMA Ophthalmol. 2018 Jun 14;136(6):e180940. doi: 10.1001/jamaophthalmol.2018.0940. Epub 2018 Jun 14. No abstract available.

PMID:
29902319
22.

Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.

Abramson DH, Ji X, Francis JH, Catalanotti F, Brodie SE, Habib L.

Br J Ophthalmol. 2019 Apr;103(4):488-493. doi: 10.1136/bjophthalmol-2018-312037. Epub 2018 Jun 6.

PMID:
29875233
23.

Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.

Francis JH, Levin AM, Zabor EC, Gobin YP, Abramson DH.

PLoS One. 2018 May 23;13(5):e0197081. doi: 10.1371/journal.pone.0197081. eCollection 2018.

24.

Choroidal infarction following ophthalmic artery chemotherapy.

Bohm KJ, Gobin YP, Francis JH, McInerney G, Dabo-Trubelja A, Dalecki PH, Marr BP, Abramson DH.

Int J Retina Vitreous. 2018 Apr 30;4:16. doi: 10.1186/s40942-018-0119-x. eCollection 2018.

25.

Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery.

Akella SS, Francis JH, Knezevic A, Ostrovnaya I, Gobin YP, Friedman D, Guarini E, Eibeler L, Catalanotti F, Abramson DH.

PLoS One. 2018 May 7;13(5):e0197052. doi: 10.1371/journal.pone.0197052. eCollection 2018.

26.

Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma.

Friedman DN, Chou JF, Francis JH, Sklar CA, Li Y, McCabe M, Robison LL, Kleinerman RA, Oeffinger KC, Abramson DH, Dunkel IJ, Ford JS.

JAMA Ophthalmol. 2018 Jun 1;136(6):637-641. doi: 10.1001/jamaophthalmol.2018.1082.

27.

Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.

Rowlands MA, Mondesire-Crump I, Levin A, Mauguen A, Francis JH, Dunkel IJ, Brodie SE, Gobin YP, Abramson DH.

PLoS One. 2018 Apr 26;13(4):e0195395. doi: 10.1371/journal.pone.0195395. eCollection 2018.

28.

Reply.

Francis JH, Abramson DH, Habib L, Yannuzzi LA, Catalanotti F.

Ophthalmology. 2018 Apr;125(4):e31. doi: 10.1016/j.ophtha.2017.11.002. No abstract available.

PMID:
29566879
29.

Clinicopathologic Correlation of Choroidal Invasion in Retinoblastoma.

Abramson DH, Folberg R, Francis JH.

Ophthalmology. 2018 Apr;125(4):568. doi: 10.1016/j.ophtha.2017.11.037. No abstract available.

PMID:
29566869
30.

Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.

Abramson DH, Catalanotti F, Brodie SE, Kellick MG, Francis JH.

Ophthalmic Genet. 2018 Jun;39(3):353-356. doi: 10.1080/13816810.2018.1443343. Epub 2018 Mar 7.

PMID:
29513055
31.

BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.

Francis JH, Grossniklaus HE, Habib LA, Marr B, Abramson DH, Busam KJ.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):117-121. doi: 10.1167/iovs.17-22517.

32.

Choroidal Invasion in Retinoblastoma Treated with Intrarterial Chemotherapy.

Abramson DH, Francis JH, Gobin YP.

Ophthalmol Retina. 2018 Jan;2(1):9. doi: 10.1016/j.oret.2017.08.022. Epub 2018 Jan 3. No abstract available.

PMID:
31047314
33.

Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy.

Francis JH, Abramson DH, Ji X, Shields CL, Teixeira LF, Schefler AC, Cassoux N, Hadjistilianou D, Berry JL, Frenkel S, Munier FL.

JAMA Ophthalmol. 2017 Dec 1;135(12):1426-1429. doi: 10.1001/jamaophthalmol.2017.4600.

34.

Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide.

Abramson DH, Shields CL, Jabbour P, Teixeira LF, Fonseca JRF, Marques MCP, Munier FL, Puccinelli F, Hadjistilianou T, Bracco S, Chantada G, Ceciliano A, Gobin YP.

Int J Retina Vitreous. 2017 Oct 23;3:40. doi: 10.1186/s40942-017-0093-8. eCollection 2017.

35.

Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.

Francis JH, Habib LA, Abramson DH.

Adv Ophthalmol Optom. 2017 Aug;2(1):177-195. doi: 10.1016/j.yaoo.2017.03.008. No abstract available.

36.

Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study.

Boddu SR, Abramson DH, Marr BP, Francis JH, Gobin YP.

J Neurointerv Surg. 2017 Nov;9(11):1107-1112. doi: 10.1136/neurintsurg-2016-012758. Epub 2016 Nov 9.

PMID:
29030462
37.

SKP2 Activation by Thyroid Hormone Receptor β2 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells.

Xu XL, Li Z, Liu A, Fan X, Hu DN, Qi DL, Chitty DW, Jia R, Qui J, Wang JQ, Sharaf J, Zou J, Weiss R, Huang H, Joseph WJ, Ng L, Rosen R, Shen B, Reid MW, Forrest D, Abramson DH, Singer S, Cobrinik D, Jhanwar SC.

Cancer Res. 2017 Dec 15;77(24):6838-6850. doi: 10.1158/0008-5472.CAN-16-3299. Epub 2017 Sep 28.

38.

Growth of Uveal Melanoma following Intravitreal Bevacizumab.

Francis JH, Kim J, Lin A, Folberg R, Iyer S, Abramson DH.

Ocul Oncol Pathol. 2017 Jul;3(2):117-121. doi: 10.1159/000450859. Epub 2016 Nov 12.

39.

An international survey of classification and treatment choices for group D retinoblastoma.

Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe'er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA.

Int J Ophthalmol. 2017 Jun 18;10(6):961-967. doi: 10.18240/ijo.2017.06.20. eCollection 2017.

40.

Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.

Francis JH, Habib LA, Abramson DH, Yannuzzi LA, Heinemann M, Gounder MM, Grisham RN, Postow MA, Shoushtari AN, Chi P, Segal NH, Yaeger R, Ho AL, Chapman PB, Catalanotti F.

Ophthalmology. 2017 Dec;124(12):1788-1798. doi: 10.1016/j.ophtha.2017.05.038. Epub 2017 Jul 12.

41.

Peripheral leptochoroid: clinical and anatomical findings.

Francis JH, Habib LA, Abramson DH.

Br J Ophthalmol. 2018 Jan;102(1):120-125. doi: 10.1136/bjophthalmol-2017-310406. Epub 2017 Jun 16.

PMID:
28625971
42.

Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years.

Habib LA, Francis JH, Fabius AW, Gobin PY, Dunkel IJ, Abramson DH.

Br J Ophthalmol. 2018 Feb;102(2):272-275. doi: 10.1136/bjophthalmol-2017-310328. Epub 2017 Jun 9.

PMID:
28600304
43.

Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.

Francis JH, Iyer S, Gobin YP, Brodie SE, Abramson DH.

Ophthalmology. 2017 Oct;124(10):1548-1555. doi: 10.1016/j.ophtha.2017.04.010. Epub 2017 May 22.

PMID:
28545735
44.

Ocular Argyrosis Mimicking Conjunctival Melanoma.

Tendler I, Pulitzer MP, Roggli V, Abramson DH, Marr BP.

Cornea. 2017 Jun;36(6):747-748. doi: 10.1097/ICO.0000000000001191.

45.

Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.

Pappas L, Xu XL, Abramson DH, Jhanwar SC.

Adv Biol Regul. 2017 May;64:20-32. doi: 10.1016/j.jbior.2017.01.002. Epub 2017 Feb 8.

PMID:
28242412
46.

Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.

Abramson DH, Fabius AW, Francis JH, Marr BP, Dunkel IJ, Brodie SE, Escuder A, Gobin YP.

Ophthalmic Genet. 2017 Jan-Feb;38(1):16-21. doi: 10.1080/13816810.2016.1244695. Epub 2017 Jan 17.

47.

Anesthetic complications during general anesthesia without intravenous access in pediatric ophthalmologic clinic: assessment of 5216 cases.

Hung CW, Licina L, Abramson DH, Arslan-Carlon V.

Minerva Anestesiol. 2017 Jul;83(7):712-719. doi: 10.23736/S0375-9393.17.11565-8. Epub 2017 Jan 17.

48.

Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.

Karl MD, Francis JH, Iyer S, Marr B, Abramson DH.

J Pediatr Ophthalmol Strabismus. 2017 May 1;54(3):185-190. doi: 10.3928/01913913-20161116-01. Epub 2017 Jan 17.

49.

Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.

Francis JH, Brodie SE, Marr B, Zabor EC, Mondesire-Crump I, Abramson DH.

Ophthalmology. 2017 Apr;124(4):488-495. doi: 10.1016/j.ophtha.2016.12.015. Epub 2017 Jan 12.

50.

Anterior Segment Retinoblastoma.

Abramson DH, Folberg R, Francis JH.

Ophthalmol Retina. 2017 Nov - Dec;1(6):561. doi: 10.1016/j.oret.2017.08.004. Epub 2017 Nov 1. No abstract available.

PMID:
31047455

Supplemental Content

Loading ...
Support Center